Imagine a world where the genetic code is as easy to edit as a simple copy-and-paste. This is the reality of CRISPR, a ...

Professor Kevin J. Zwezdaryk and Chandler H. Monk discuss CRISPR and diagnostics, focusing on the development of a portable ...

Researchers at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena, in collaboration with international partners, have made a ...

Shortly after arriving in Ottawa with her two young children, following her husband's appointment as Cameroon's High Commissioner (Ambassador) to Canada, Mercy Azoh-Mbi complained of fatigue, fever, a ...

QuidelOrtho Corporation (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, ...

Mars is a strange place and any humans born there are bound to look radically different over thousands or even hundreds of ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...